Breast Cancer: CDK Inhibitor

Good Day Live

Julie spoke with Dr. Dennis J. Slamon is the Director of Clinical Research at the Johnson Comprehensive Cancer Center at UCLA and shared more about a new study using a new type of CDK Inhibitor.

Copyright 2020 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Don't Miss

More Don't Miss

Trending Stories